Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Cancer Research|July 12, 2011
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expressionMarkus Chmielewski, Caroline Kopecky, Andreas A Hombach, et al.Gene Therapy|March 2, 2012
T cells redirected by a CD3ζ chimeric antigen receptor can establish self-antigen-specific tumour protection in the long termM Chmielewski, G Rappl, A A Hombach, et al.Gene Therapy|August 6, 2003
T-cell activation by recombinant immunoreceptors: impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cellsC Heuser, A Hombach, C Lösch, et al.Zeitschrift Fur Gastroenterologie|February 24, 2001
[Aminosalicylates and aspirin for colonic cancer: from anti-inflammatory to antineoplastic drugs?]H Allgayer, T Tillmann, A Hombach, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 30, 2018
CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine LoopViktória Golumba-Nagy, Johannes Kuehle, Andreas A Hombach, et al.Cells|January 21, 2023
A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2<sup>+</sup> Solid CancerAndreas A Hombach, Christine Ambrose, Roy Lobb, et al.Oncoimmunology|July 4, 2012
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cellsAndreas A Hombach, Johannes Heiders, Marcel Foppe, et al.Rejuvenation Research|September 23, 2008
Extensive amplification of human regulatory T cells alters their functional capacities and targets them to the peripheryGunter Rappl, Annette Schmidt, Cornelia Mauch, et al.Advances in Hematology|August 13, 2011
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemiaPhilipp Koehler, Patrick Schmidt, Andreas A Hombach, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2Andreas A Hombach, David Kofler, Anja Hombach, et al.Pageof 8